We are live on ! Find out more
OLMA icon

Olema Pharmaceuticals
OLMA

74 hedge funds and large institutions have $1.16B invested in Olema Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 15 increasing their positions, 13 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

106% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 16

30% more funds holding

Funds holding: 57 → 74 (+17)

15% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 13

3.32% less ownership

Funds ownership: 91.05% → 87.73% (-3.3%)

17% less funds holding in top 10

Funds holding in top 10: 6 → 5 (-1)

30% less capital invested

Capital invested by funds: $1.66B → $1.16B (-$499M)

Holders
74
Holders Change
+17
Holders Change %
+29.82%
% of All Funds
1.3%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.09%
New
33
Increased
15
Reduced
13
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$32.9M
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$8.04M
3
State Street
State Street
Massachusetts
+$7.45M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$5.25M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$4.99M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$18.2M
2
FCMI
Foresite Capital Management IV
California
-$18.2M
3
APM
Avidity Partners Management
Texas
-$13M
4
Invesco
Invesco
Georgia
-$12.2M
5
DCM
Driehaus Capital Management
Illinois
-$4.35M
Name Holding Trade Value Shares
Change 		Change in
Stake
State Street
26
State Street
Massachusetts
$5.77M +$7.45M +173,846 New
DCM
27
Driehaus Capital Management
Illinois
$5.7M -$4.35M -101,573 -37%
PAMU
28
Pictet Asset Management (UK)
United Kingdom
$5.65M +$405K +9,458 +6%
Northern Trust
29
Northern Trust
Illinois
$4.32M +$4.98M +116,206 +836%
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
$3.87M +$4.99M +116,529 New
JP Morgan Chase
31
JP Morgan Chase
New York
$3.33M +$1.15M +26,807 +36%
Point72 Asset Management
32
Point72 Asset Management
Connecticut
$3.12M +$4.02M +93,900 New
Charles Schwab
33
Charles Schwab
California
$2.61M +$3.37M +78,616 New
Morgan Stanley
34
Morgan Stanley
New York
$2.04M +$672K +15,690 +34%
N
35
Nuveen
North Carolina
$1.47M +$1.89M +44,196 New
Susquehanna International Group
36
Susquehanna International Group
Pennsylvania
$1.44M +$6.64K +155 +0.4%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$1.06M +$1.37M +32,030 New
PPA
38
Parametric Portfolio Associates
Washington
$1M +$237K +5,519 +22%
Bank of America
39
Bank of America
North Carolina
$910K +$1.17M +27,321 +28,759%
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$737K -$89.9K -2,097 -9%
Goldman Sachs
41
Goldman Sachs
New York
$700K -$1.46M -34,064 -62%
California State Teachers Retirement System (CalSTRS)
42
California State Teachers Retirement System (CalSTRS)
California
$607K +$784K +18,299 New
AC
43
Athanor Capital
New York
$533K +$465K +10,848 +208%
HS
44
HighVista Strategies
Massachusetts
$480K +$619K +14,455 New
JRP
45
Jasper Ridge Partners
California
$475K +$613K +14,313 New
Deutsche Bank
46
Deutsche Bank
Germany
$447K +$577K +13,476 New
SAM
47
Sectoral Asset Management
Quebec, Canada
$428K +$553K +12,900 New
JCM
48
JS Capital Management
New York
$422K +$545K +12,723 New
HLA
49
Hamilton Lane Advisors
Pennsylvania
$402K +$519K +12,114 New
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$364K +$470K +10,966 New
1
2
3 4

OLMA Hedge Fund Activity: Q1 2021 in Review

74 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Olema Pharmaceuticals (OLMA) for Q1 2021, worth a combined $1.16B — down 30% from $1.66B a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new OLMA positions and 16 closed out — a net gain of 17 holders — while 15 added to existing stakes and 13 trimmed.

The largest buyer was BlackRock, adding an estimated $32.9M. The largest seller was Deerfield Management, cutting an estimated $18.2M.

  • 74 institutional investors held Olema Pharmaceuticals (OLMA) as of Q1 2021, up from 57 in Q4 2020.
  • Funds reported $1.16B of Olema Pharmaceuticals stock for Q1 2021, down 30% quarter-over-quarter.
  • 33 funds opened new Olema Pharmaceuticals positions in Q1 2021 and 16 closed out, a net change of +17 holders.
  • The largest Olema Pharmaceuticals buyer in Q1 2021 was BlackRock, an estimated $32.9M added.
  • The largest Olema Pharmaceuticals seller in Q1 2021 was Deerfield Management, an estimated $18.2M sold.

Based on aggregated 13F filings for Q1 2021.